# OnCo record paper-li-accuscan-embo-mol-med-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-li-accuscan-embo-mol-med-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-li-accuscan-embo-mol-med-2024" ;
  schema:name "Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction"@en ;
  schema:description "A whole-genome blood test that corrects errors read by read detected tumour DNA at about ten parts per million and predicted relapse after bowel cancer surgery."@en ;
  schema:url <https://onco.cc/key-papers/paper-li-accuscan-embo-mol-med-2024/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s44321-024-00115-0>, <https://pubmed.ncbi.nlm.nih.gov/39164471/> ;
  schema:sameAs <https://doi.org/10.1038/s44321-024-00115-0> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Li X, Liu T, Bacchiocchi A, et al." ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/melanoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/wes-wgs/> ;
  onco:drugs <https://onco.cc/drugs/accuscan-mrd/> ;
  onco:companies <https://onco.cc/companies/accuragen/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> .